Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2312 (LINC02312)

Target
LINC02312
Molecular classification
Other (specifically, long intergenic non-coding RNA or lincRNA)
01

Overview

Long intergenic non-protein coding RNA 2312 (LINC02312) is a long non-coding RNA gene that does not encode a protein but produces a non-coding RNA transcript of more than 200 nucleotides. Such lincRNAs have been characterized as regulatory elements with diverse functions in the cell, notably gene expression regulation (including acting in *cis* or *trans* on other genetic loci), epigenetic modification of chromatin, influencing mRNA processing, and potentially contributing to cell cycle and cell size control. While dysregulation of lncRNAs more broadly is involved in various human diseases, including cancers and metabolic disorders, there is currently no evidence specifically associating LINC02312 with disease nor as a direct therapeutic target. LINC02312 is sometimes cataloged in genomic databases, such as NCBI Gene (Gene ID: 100132612) and Ensembl (ENSG00000258869), but its function and roles remain understudied. There are no known specific drugs, biomarkers, safety concerns, or clinical applications described for this target.

Other names
LINC02312long intergenic non-protein coding RNA 2312
02

Biological functions

Gene regulation (including transcriptional and post-transcriptional modulation)Epigenetic regulation (chromatin remodeling, histone modification)Possible regulation of cell cycle and cell size (general for lincRNAs)
03

Disease associations

Other (general lincRNA dysregulation has been implicated in cancer, Alzheimer's disease, cardiovascular disease, autoimmune diseases, and metabolic disorders, but no specific disease role described for LINC02312)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2312 (LINC02312).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2312 (LINC02312).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call